Abstract
The prostate gland is said to be immunologically privileged because it lacks afferent lymphatics and because of the immunosuppressive properties of seminal fluid. To elicit the presence or absence of an immune response within the diseased prostate gland, the infiltrate in prostate glands affected by hyperplasia or adenocarcinoma was phenotypically characterised, using immunohistochemical techniques. An infiltrate, composed mainly of T-lymphocytes (CD-3+), was demonstrated in all glands examined. No difference in the type, level of activation or degree of infiltration was found between those glands affected by hyperplasia (n = 20) and those affected by adenocarcinoma (n = 20). In the malignant cases, there was no correlation between grade (Gleason) or stage (TNM) and the type or degree of mononuclear cell infiltrate. Our findings suggest that the host response, in situ, to hyperplasia and adenocarcinoma is similar and may reflect the fact that the two diseases are often found concurrently in the same gland and in close proximity to one another. The infiltrate, therefore, is unlikely to represent a tumour specific immune response to tumour specific antigens. The significant infiltrate we have demonstrated, and its phenotypic characterisation, would not support the hypothesis that the prostate is immunologically privileged as has been suggested previously.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 24 print issues and online access
$259.00 per year
only $10.79 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
McClinton, S., Miller, I. & Eremin, O. An immunohistochemical characterisation of the inflammatory cell infiltrate in benign and malignant prostatic disease. Br J Cancer 61, 400–403 (1990). https://doi.org/10.1038/bjc.1990.87
Issue Date:
DOI: https://doi.org/10.1038/bjc.1990.87
This article is cited by
-
Icariin ameliorates metabolic syndrome-induced benign prostatic hyperplasia in rats
Environmental Science and Pollution Research (2022)
-
Human microbiome and prostate cancer development: current insights into the prevention and treatment
Frontiers of Medicine (2021)
-
Human prostate supports more efficient replication of HIV-1 R5 than X4 strains ex vivo
Retrovirology (2008)
-
Impaired access of lymphocytes to neoplastic prostate tissue is associated with neoangiogenesis in the tumour site
British Journal of Cancer (2007)
-
Persistently high levels of immunosuppressive cytokines in patients after radical prostatectomy
Prostate Cancer and Prostatic Diseases (2006)